Evidence map›Paper›PMID 42158302›Full record

ArticleCurrent journal of neurology2025

Infections in patients with multiple sclerosis treated with disease-modifying therapies: A comparative risk assessment cohort study.

Mohammad Reza Fattahi, Amir Valizadeh, Amirreza Azimi, Abdorreza Naser Moghadasi, Moein Ghasemi, Samira Navardi, Rozita Doosti, Zahra Hemmati, Ali Zare-Dehnavi, Arad Iranmehr and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mohammad Reza FattahiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amir ValizadehNeuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amirreza AzimiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abdorreza Naser MoghadasiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Moein GhasemiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Samira NavardiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Rozita DoostiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Zahra HemmatiDepartment of Stroke, Epsom and St Helier University Hospitals, Epsom, KT18 7EG, UK.
Ali Zare-DehnaviMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Arad IranmehrNeurosurgery Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Sara Hamtaei-GashtiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali SahraianMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AzathioprineFingolimodInfectionsInterferonsMultiple SclerosisRituximab

Identifiers

PMID42158302
PMCPMC13183252

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.